Jennifer A. Creedon

image_pdf

Jennifer A. Creedon – Partner
Boston, Massachusetts

Direct: (857) 957-0683
Phone: (617) 227-3240
Fax: (617) 227-3346

jcreedon@mmmk.com

Download vCard

LinkedIn

 

Jennifer Creedon is a trial attorney who represents large and small companies in asbestos litigation, product liability litigation, and business litigation. Whether a company’s litigation is confined to one lawsuit or requires a multi-lawsuit solution, Jen can craft a defense strategy that fits the company’s needs.

Jen has defended toxic tort and product liability actions in Massachusetts, Rhode Island and Connecticut. She has served as local, regional and national counsel for companies involved in toxic tort and asbestos litigation. Jen has been part of a national counsel team for a Fortune 500 company and designed national trial strategy, involving preparation of corporate witnesses, expert witnesses and drafted nationwide discovery. In that capacity, she has handled cases in Massachusetts, Rhode Island, California, Connecticut, Delaware, Illinois, Indiana, Louisiana, Maine, Maryland, Mississippi, Missouri, New York, Ohio, Pennsylvania, Texas and Washington. Additionally, she has handled Federal Multidistrict Litigation including cases consolidated in MDL 875 (In Re: Asbestos Product Liability Litigation (No. VI)) and the Maritime Docket (MARDOC). As an adjunct to handling a company’s complex litigation, Jen can coordinate compliance with the Medicare Secondary Payer Act and all associated regulations and legislation including the Medicare, Medicaid and the SCHIP Extension Act of 2007 (MMSEA/Mandatory Settlement Reporting).

Jen has defended product liability and toxic tort cases involving a wide range of chemicals, resins, paints, construction products, joint compounds and wallboards, roofing materials, floor tiles, refractory products, boilers, brakes and other automobile components, refineries, shipyards, and industrial and chemical premises. Jen has an in-depth understanding of regulations, industry standards, state-of-the-art defenses, industrial hygiene defenses, medical defenses, and experts in both product and premise based toxic tort litigation. She has defended design defect cases relating to bicycles, construction equipment, industrial equipment and medical equipment. Jen has prepared and argued appeals before the United States Court of Appeals for the First Circuit and the Massachusetts Appellate Court.

Jen has years of experience defending talc defendants and is poised to defend any company involved in the newly emerging and new frontier of talc litigation.  Jen is cognizant of the high stakes nature of this possible “next asbestos” and is highly vigilant in representing her clients to protect their bottom lines.

Bar Admissions:
Massachusetts, 1997
Rhode Island, 2004
Connecticut, 2015

Court and Other Admissions:
U.S. District Court for the District of Massachusetts, 2001
U.S. District Court for the District of Rhode Island, 2006
U.S. Court of Appeals for the First Circuit, 2006

Clerkships:
Massachusetts Superior Court

Education:
Boston College Law School, 1997
J.D.
Honors: cum laude

Boston College, 1993
B.A.
Honors: cum laude, Order of the Cross and Crown

Honors and Awards:
AV Rated by Martindale-Hubbell
Recognized as a 2015 Client Service All-Star by BTI Consulting Group
Listed in The Best Lawyers in America© under Product Liability Litigation – Defendants
Selected by peers for inclusion in New England Super Lawyers© under Class Action/Mass Torts, Personal Injury – Products: Defense

Professional Associations and Memberships:
Boston Bar Association
Co-Chair, Tort Section, Boston Bar Association (2010-2011)
Junior Fellow, Boston Bar Association
Rhode Island Bar Association
Defense Research Institute

For two years, Jen served as the BBA Tort Chair and has developed CLE programs in Massachusetts relating to product liability and toxic tort.  Jen is a current member of the Board of the Mass DLA. Jen frequently writes and speaks on Mass Tort Litigation developments and best practices.  Her speaking engagements include the following:

The Latest Medicare Advantage Decisions: Their Significance and Loopholes, Analyzed
The Knowledge Group (January 27, 2017)

Single Fiber Theory
DRI 2015 Asbestos Medicine Seminar (November 5, 2015)

Understanding the Effects of Sequenced Discovery Mass Tort Litigation (Case    Study: Talc and Asbestos Litigation)
The Knowledge Group (September 9, 2016)

Understanding the Effects of Sequenced Discovery Mass Tort Litigation
The Knowledge Group (2015)

Corporate Client Panel: Issues in Asbestos Litigation
DRI Defense Practice Seminar – Asbestos Medicine (November 7, 2013)

MMSEA Section 111 and Asbestos Litigation:  The Advantages of Dealing with the Elephantine Mass
HB Legal News: Medicare Secondary Payer (April 2010)

Medicare, Medicaid and SCHIP Extension Act of 2007:  What you need to know if you will settle a case in 2010
Boston Bar Association (November 29, 2009)

Content Liability:  What every corporate counsel needs to know, MCLE Sponsor as Co-Chair of Tort Section Committee
Boston Bar Association (June 9, 2010)

Canavan: Unlocking the Strategic Opportunities
Massachusetts Lawyers Weekly (Co-Author)